About Dan Estes
Form D filings for Radionetics Oncology in 2023 list Dan Estes as executive officer and director.
Dan Estes first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Dan Estes in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dan Estes works with at each company, as listed on that company's latest Form D.
Radionetics Oncology, Inc. · Form D, Aug 15, 2023
BE
Brett Ewald
Interim Chief Operating Officer
AS
Andrew Schwab
Director
UG
Umesh Gangadharmath
Executive officer
IM
Istvan Molnar
Executive officer
YZ
Yunfei Zhu
Executive officer
AK
Ana Kusnetzow
Executive officer
SS
Scott Struthers
Director